QQ客服 官方微博 反馈留言

浏览/检索结果: 共8条，第1-8条 帮助 限定条件 专题：吉林大学白求恩第一医院    第一署名单位    第一作者单位    通讯作者单位     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Does all single infarction have lower risk of stroke recurrence than multiple infarctions in minor stroke? 期刊论文 BMC NEUROLOGY, 2019, 卷号: 19 作者:  Li, Hao;  Wang, Guangyao;  Jing, Jing;  Pan, Yuesong;  Meng, Xia 收藏  |  浏览/下载：126/0  |  提交时间：2019/12/05 Minor stroke  Infarction patterns  Prognosis   The cost of Alzheimer's disease in China and re-estimation of costs worldwide 期刊论文 ALZHEIMERS & DEMENTIA, 2018, 卷号: 14, 期号: 4 作者:  Jia, Jianping;  Wei, Cuibai;  Chen, Shuoqi;  Li, Fangyu;  Tang, Yi 收藏  |  浏览/下载：32/0  |  提交时间：2019/12/05 Rituximab plus chemotherapy as first-line treatment in Chinese patients with diffuse large B-cell lymphoma in routine practice: a prospective, multicentre, non-interventional study 期刊论文 BMC CANCER, 2016, 卷号: 16 作者:  Wu, Jianqiu;  Song, Yongping;  Su, Liping;  Xu, Li;  Chen, Tingchao 收藏  |  浏览/下载：13/0  |  提交时间：2019/12/05 DLBCL  R-CHOP  Chemotherapy  HBV infection  HBsAg   A single-arm, multicenter, safety-monitoring, phase IV study of icotinib in treating advanced non-small cell lung cancer (NSCLC) 期刊论文 LUNG CANCER, 2014, 卷号: 86, 期号: 2 作者:  Hu, Xingsheng;  Han, Baohui;  Gu, Aiqin;  Zhang, Yiping;  Jiao, Shun Chang 收藏  |  浏览/下载：7/0  |  提交时间：2019/12/05 Non-small-cell lung cancer  Icotinib  EGFR TKIs  Phase IV  real-world study  safety  efficacy   A Prospective, Observational Study on the Safety and Effectiveness of Rituximab Plus Chemotherapy As the First-Line Treatment of Diffuse Large B-Cell Lymphoma 会议论文 作者:  Sun, Zimin;  Feng, Jifeng;  Wu, Jianqiu;  Song, Yongping;  Su, Liping 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05 A Prospective, Observational Study on the Safety and Effectiveness of Rituximab Plus Chemotherapy As the First-Line Treatment of Diffuse Large B-Cell Lymphoma 期刊论文 BLOOD, 2014, 卷号: 124, 期号: 21 作者:  Zeng, Yun;  Cui, Tongjian;  Bai, Hai;  Sun, Zimin;  Wang, Jishi 收藏  |  浏览/下载：5/0  |  提交时间：2019/12/05 Safety and efficacy results of a phase IV, open-label, multicenter, safety-monitoring study of icotinib in treating advanced non-small cell lung cancer (NSCLC): ISAFE study. 期刊论文 JOURNAL OF CLINICAL ONCOLOGY, 2013, 卷号: 31, 期号: 15 作者:  Tan, Fenlai;  Gu, Aiqin;  Zhang, Yiping;  Jiao, Shun Chang;  Wang, Chang-Li 收藏  |  浏览/下载：8/0  |  提交时间：2019/12/05 Safety and efficacy results of a phase IV, open-label, multicenter, safety-monitoring study of icotinib in treating advanced non-small cell lung cancer (NSCLC): ISAFE study. 期刊论文 JOURNAL OF CLINICAL ONCOLOGY, 2013, 卷号: 31, 期号: 15 作者:  Tan, Fenlai;  Gu, Aiqin;  Zhang, Yiping;  Jiao, Shun Chang;  Wang, Chang-Li 收藏  |  浏览/下载：9/0  |  提交时间：2019/12/05